Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host.
about
Novel immunotherapies for hematologic malignanciesIdentification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencingIn vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomesIL-12 is required for mTOR regulation of memory CTLs during viral infection.Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent.Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells.IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapy.IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cellsTrial Watch: Adoptive cell transfer for anticancer immunotherapy.Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signalingPlatelets subvert T cell immunity against cancer via GARP-TGFβ axis.Harnessing the IL-7/IL-7Rα axis to improve tumor immunotherapy.
P2860
Q27004436-BD2C0474-B7D9-44CA-BB11-A6E2566C677FQ27334215-C0E64F6D-C97F-410C-A06A-26234D4F041BQ33716478-DCC43AB2-E284-4FC5-B9A6-1F0964D5F7A4Q34143415-4648EC05-250E-4DA4-8535-D4722F02F527Q36616920-3902AFCA-16B0-4E51-B898-2057FAC22BCEQ36721440-EEC5C955-D36B-4919-AF8C-76CE59143655Q36722289-E7CD6DA1-3F4C-45F2-B3AA-21993B6CA3CBQ36727794-B5957BEF-301F-4B32-90F0-46DA9E9FF9A4Q36887833-46327488-A548-4332-83AB-7616CE766EDEQ37730632-B5F2C556-49CF-4BAE-A6FA-57127002DF6DQ41208347-7612B33D-5F6D-4364-83BC-4F3C1ABD137EQ42695101-3534265A-488D-4F0C-8B69-D84D18D74885
P2860
Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ex vivo interleukin-12-priming ...... cacy in a lymphodepleted host.
@ast
Ex vivo interleukin-12-priming ...... cacy in a lymphodepleted host.
@en
type
label
Ex vivo interleukin-12-priming ...... cacy in a lymphodepleted host.
@ast
Ex vivo interleukin-12-priming ...... cacy in a lymphodepleted host.
@en
prefLabel
Ex vivo interleukin-12-priming ...... cacy in a lymphodepleted host.
@ast
Ex vivo interleukin-12-priming ...... cacy in a lymphodepleted host.
@en
P2093
P2860
P1476
Ex vivo interleukin-12-priming ...... icacy in a lymphodepleted host
@en
P2093
C Bryce Johnson
Caitlin J Moore
Chrystal M Paulos
Colleen A Cloud
David H Craig
David J Cole
Kristina M Schwartz
Mark P Rubinstein
Tracy E Garrett
P2860
P304
700-7; discussion 707-8
P356
10.1016/J.JAMCOLLSURG.2011.12.034
P577
2012-02-22T00:00:00Z